Search results
Sei Investments Co. Has $161.63 Million Stock Position in Merck & Co., Inc. (NYSE:MRK)
ETF DAILY NEWS· 17 hours agoSei Investments Co. lowered its stake in Merck & Co., Inc. (NYSE:MRK – Free Report) by 2.3% during the fourth quarter, HoldingsChannel.com reports. The ...
Waterloo Capital L.P. Acquires Shares of 4,004 Merck & Co., Inc. (NYSE:MRK)
ETF DAILY NEWS· 2 days agoWaterloo Capital L.P. bought a new position in shares of Merck & Co., Inc. (NYSE:MRK – Free Report) in the 4th quarter, according to its most recent Form ...
Nike, Merck, General Motors, And More: CNBC's 'Final Trades' - Nike (NYSE:NKE)
Benzinga· 17 hours agoLiz Young of SoFi recommends Energy Select Sector SPDR Fund as her final trade on CNBC's Halftime Report. Jim Lebenthal of Cerity Partners picks General Motors, while Jason Snipe of Odyssey ...
Investors more bullish on Merck (NYSE:MRK) this week as stock climbs 4.1%, despite earnings trending...
Simply Wall St. via Yahoo Finance· 2 days agoBy buying an index fund, you can roughly match the market return with ease. But if you choose...
Moderna and MSD share encouraging three-year data from trial of melanoma therapy
Clinical Trials Arena via Yahoo Finance· 7 days agoPharmaceutical companies Moderna and Merck & Co (MSD) have announced positive results from the Phase...
Merck shares maintain Outperform rating amid ongoing clinical trials By Investing.com
Investing.com· 6 days agoOn Tuesday, BMO Capital maintained its Outperform rating on Merck & Co. Inc. (NYSE:MRK), with a...
Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon
Benzinga via Yahoo Finance· 6 days agoOn Monday, Moderna (NASDAQ: MRNA) and Merck & Co (NYSE: MRK) also reported durable efficiency of...
The City With the highest HIV/AIDS Rates in the US
Insider Monkey via Yahoo Finance· 4 days agoWe recently compiled a list of 20 Cities With the Highest HIV/AIDS Rates in the US and in this article, we will talk about the city with the highest...
ASCO: Cautious Big Pharmas double down on past wins—steering clear of radioligands and cell therapy
FierceBiotech· 6 days ago“I think that people finally are showing up like in the old days,” Eliav Barr, M.D., Merck & Co.’s...
3 No-Brainer Nasdaq Stocks to Buy in June
247wallst.com· 12 hours agoInvestors looking for a ton of value and a place to put some of the gains from the huge technology move should consider these top stocks.